1. Home
  2. CWCO vs EDIT Comparison

CWCO vs EDIT Comparison

Compare CWCO & EDIT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Consolidated Water Co. Ltd.

CWCO

Consolidated Water Co. Ltd.

HOLD

Current Price

$28.68

Market Cap

478.2M

Sector

Utilities

ML Signal

HOLD

Logo Editas Medicine Inc.

EDIT

Editas Medicine Inc.

HOLD

Current Price

$3.76

Market Cap

432.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CWCO
EDIT
Founded
1973
2013
Country
Cayman Islands
United States
Employees
N/A
N/A
Industry
Water Supply
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Utilities
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
478.2M
432.8M
IPO Year
1997
2016

Fundamental Metrics

Financial Performance
Metric
CWCO
EDIT
Price
$28.68
$3.76
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
5
Target Price
$40.00
$5.30
AVG Volume (30 Days)
104.9K
2.7M
Earning Date
05-11-2026
05-11-2026
Dividend Yield
1.73%
N/A
EPS Growth
N/A
37.50
EPS
0.23
N/A
Revenue
$132,073,368.00
$31,937,000.00
Revenue This Year
$4.34
N/A
Revenue Next Year
$42.86
N/A
P/E Ratio
$124.65
N/A
Revenue Growth
N/A
132.64
52 Week Low
$28.17
$1.66
52 Week High
$39.12
$4.54

Technical Indicators

Market Signals
Indicator
CWCO
EDIT
Relative Strength Index (RSI) 36.26 72.77
Support Level $28.70 $1.93
Resistance Level $30.69 $3.94
Average True Range (ATR) 0.71 0.25
MACD 0.01 0.13
Stochastic Oscillator 10.64 96.93

Price Performance

Historical Comparison
CWCO
EDIT

About CWCO Consolidated Water Co. Ltd.

Consolidated Water Co Ltd is a water utility company. It develops and operates seawater desalination plants and water distribution systems. The company's business segments are; The retail segment operates the water utility for the Seven Mile Beach and West Bay areas of Grand Cayman Island, The bulk segment supplies potable water to government utilities in Grand Cayman and The Bahamas under long-term contracts, The services segment designs, constructs and sells water infrastructure and provides management and operating services to third parties. The manufacturing segment manufactures and services a wide range of custom and specialized water-related products applicable to commercial, municipal, and industrial water production, supply, and treatment, and the corporate segment.

About EDIT Editas Medicine Inc.

Editas Medicine Inc is a clinical-stage genome editing company dedicated to developing potentially transformative genomic medicines to treat a broad range of serious diseases. The company focuses on developing a proprietary gene editing platform based on CRISPR technology and continues to expand its capabilities. CRISPR uses a protein-RNA complex composed of an enzyme, including either Cas9 (CRISPR-associated protein 9) or Cas12a (CRISPR from Prevotella and Francisella 1, also known as Cpf1). The company has a single operating segment, which is the business of developing and commercializing gene editing technology.

Share on Social Networks: